Mark E Delaney sold $1.5M of DGX
SVP & Chief Commercial Officer at QUEST DIAGNOSTICS INC. 7,946 shares at an average of $187.35, traded Nov 18, 2025, filed Nov 20, 2025.
Score components
- +15RoleOfficer
- +25Trade size$1.5M at market
- +20Share of holdings soldSold 51% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001955265-25-000004, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 18, 2025 | MOption exercise Common Stock10b5-1 | +7,846 | $144.47 | $1.1M | 15,376 | Nov 20, 2025 |
| Nov 18, 2025 | MOption exercise Common Stock10b5-1 | +100 | $143.33 | $14k | 15,476 | Nov 20, 2025 |
| Nov 18, 2025 | SOpen-market sale Common Stock10b5-1 | -7,946 | $187.35 | $1.5M | 7,530 | Nov 20, 2025 |
| Nov 18, 2025 | MOption exercise Non-Qualifed Stock Option (right to buy)derivative10b5-1 | -7,846 | $144.47 | $1.1M | 0 | Nov 20, 2025 |
| Nov 18, 2025 | MOption exercise Non-Qualifed Stock Option (right to buy)derivative10b5-1 | -100 | $143.33 | $14k | 7,484 | Nov 20, 2025 |
Related signals
Other insiders at QUEST DIAGNOSTICS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | QUEST DIAGNOSTICS INC | J. E. Davis CEO and President | $2.4M 10,000 shares | -8% | |
| 40Moderate | QUEST DIAGNOSTICS INC | J. E. Davis CEO and President | $11M 55,093 shares | -31% | |
| 43Moderate | QUEST DIAGNOSTICS INC | Vicky B Gregg director | $240k 1,250 shares | -7% | |
| 28Weak | DGXsell QUEST DIAGNOSTICS INC | Gary M Pfeiffer director | $270k 1,482 shares | -5% | |
| 0Weak | QUEST DIAGNOSTICS INC | Michael E Prevoznik SVP & General Counsel | $43k 227 shares | -1% | |
| 15Weak | QUEST DIAGNOSTICS INC | Michael E Prevoznik SVP & General Counsel | $5.3M 28,463 shares | -43% | |
| 15Weak | QUEST DIAGNOSTICS INC | Patrick Plewman SVP for Diagnostic Services | $365k 1,975 shares | -11% | |
| 8Weak | QUEST DIAGNOSTICS INC | Patrick Plewman SVP for Diagnostic Services | $829k 4,532 shares | -21% | |
| 15Weak | QUEST DIAGNOSTICS INC | Patrick Plewman SVP for Diagnostic Services | $356k 1,975 shares | -10% | |
| 18Weak | QUEST DIAGNOSTICS INC | Patrick Plewman SVP for Diagnostic Services | $969k 5,535 shares | -22% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.